Prosecution Insights
Last updated: April 19, 2026

Werewolf Therapeutics Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18315927 SEPARATION MOIETIES AND METHODS OF USE THEREOF GURLEY, JAMI MICHELLE 1647 Non-Final OA May 11, 2023
18312245 ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF CARTER, SANDRA DILLAHUNT 1674 Final Rejection May 04, 2023
17741275 ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF ALSOMAIRY, SARAH ABDOALATIF 1646 Non-Final OA May 10, 2022
17082955 SEPARATION MOIETIES AND METHODS OF USE THEREOF HAMA, JOANNE 1647 Non-Final OA Oct 28, 2020

Managing Werewolf Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month